The role of colchicine on ventricular remodelling following myocardial infarction and ischemia-reperfusion injury: article review
DOI:
https://doi.org/10.21776/ub.hsj.2024.005.04.3Keywords:
Colchicine, Ischemia-Reperfusion Injury, Myocardial Infarction Ventricular RemodellingAbstract
Acute myocardial infarction (AMI) is a major cause of cardiac dysfunction, arrhythmias, and a poor prognosis. Even though new technologies have been developed to aid in opening the culprit coronary artery and correcting ischemia-related stenosis by percutaneous coronary intervention (PCI), the ventricular remodelling that induces cardiac failure as a consequence of AMI remains unchanged. Colchicine, a versatile anti-inflammatory medication, has been documented in mitigating cardiac remodelling and enhancing cardiac function following AMI. This article provides an in-depth review of the processes by which colchicine affects ventricular remodeling after AMI, highlighting the potential role of inflammation in the pathogenesis and progression of ventricular dysfunction.
References
Leancă SA, Crișu D, Petriș AO, et al. Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment. Life. 2022;12(8):1111. doi:10.3390/life12081111
Akodad M, Sicard P, Fauconnier J, Roubille F. Colchicine and myocardial infarction: A review. Arch Cardiovasc Dis. 2020;113(10):652-659. doi:10.1016/j.acvd.2020.04.007
Mewton N, Roubille F, Bresson D, et al. Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. Circulation. 2021;144(11):859-869. doi:10.1161/CIRCULATIONAHA.121.056177
Li Y wei, Chen S xu, Yang Y, et al. Colchicine Inhibits NETs and Alleviates Cardiac Remodeling after Acute Myocardial Infarction. Cardiovasc Drugs Ther. Published online July 28, 2022. doi:10.1007/s10557-022-07326-y
Frangogiannis NG. Pathophysiology of Myocardial Infarction. In: Comprehensive Physiology. Wiley; 2015:1841-1875. doi:10.1002/cphy.c150006
Saleh M, Ambrose JA. Understanding myocardial infarction. F1000Res. 2018;7:1378. doi:10.12688/f1000research.15096.1
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20). doi:10.1161/CIR.0000000000000617
Surendran A, Atefi N, Zhang H, Aliani M, Ravandi A. Defining Acute Coronary Syndrome through Metabolomics. Metabolites. 2021;11(10):685. doi:10.3390/metabo11100685
Al-Botaty B, El-Khoely A, Elsayed E, Eissa A. Insight into the Pathophysiology of Myocardial Infarction. Journal of Advanced Pharmacy Research. 2022;6(4):223-237. doi:10.21608/aprh.2022.155725.1188
Frangogiannis NG. Pathophysiology of Myocardial Infarction. In: Comprehensive Physiology. Wiley; 2015:1841-1875. doi:10.1002/cphy.c150006
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826. doi:10.1093/eurheartj/ehad191
Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. Published online June 26, 2016:ehw224. doi:10.1093/eurheartj/ehw224
Stone GW, Selker HP, Thiele H, et al. Relationship Between Infarct Size and Outcomes Following Primary PCI. J Am Coll Cardiol. 2016;67(14):1674-1683. doi:10.1016/j.jacc.2016.01.069
Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. Journal of Clinical Investigation. 2013;123(1):92-100. doi:10.1172/JCI62874
Yamada K, Mizutani Y, Nakamura H, Ukaji T, Sato H, Koshikawa Y. Reperfusion Injury after Acute Myocardial Infarction. Dokkyo Medical Journal. 2022;1(4):274-284.
Schirone L, Forte M, D’Ambrosio L, et al. An Overview of the Molecular Mechanisms Associated with Myocardial Ischemic Injury: State of the Art and Translational Perspectives. Cells. 2022;11(7):1165. doi:10.3390/cells11071165
Algoet M, Janssens S, Himmelreich U, et al. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med. 2023;33(6):357-366. doi:10.1016/j.tcm.2022.02.005
Zhao W, Zhao J, Rong J. Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction. Oxid Med Cell Longev. 2020;2020:1-11. doi:10.1155/2020/8815349
Leancă SA, Crișu D, Petriș AO, et al. Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment. Life. 2022;12(8):1111. doi:10.3390/life12081111
Yalta K, Yilmaz MB, Yalta T, Palabiyik O, Taylan G, Zorkun C. Late Versus Early Myocardial Remodeling After Acute Myocardial Infarction: A Comparative Review on Mechanistic Insights and Clinical Implications. J Cardiovasc Pharmacol Ther. 2020;25(1):15-26. doi:10.1177/1074248419869618
Bhatt AS, Ambrosy AP, Velazquez EJ. Adverse Remodeling and Reverse Remodeling After Myocardial Infarction. Curr Cardiol Rep. 2017;19(8):71. doi:10.1007/s11886-017-0876-4
González L, Bulnes JF, Orellana MP, Muñoz Venturelli P, MartÃnez Rodriguez G. The Role of Colchicine in Atherosclerosis: From Bench to Bedside. Pharmaceutics. 2022;14(7):1395. doi:10.3390/pharmaceutics14071395
Imazio M, Nidorf M. Colchicine and the heart. Eur Heart J. 2021;42(28):2745-2760. doi:10.1093/eurheartj/ehab221
Deftereos S, Giannopoulos G, Angelidis C, et al. Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction. Circulation. 2015;132(15):1395-1403. doi:10.1161/CIRCULATIONAHA.115.017611
Cole J, Htun N, Lew R, Freilich M, Quinn S, Layland J. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial. Circ Cardiovasc Interv. 2021;14(5). doi:10.1161/CIRCINTERVENTIONS.120.009992
Deftereos S, Giannopoulos G, Angelidis C, et al. Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction. Circulation. 2015;132(15):1395-1403. doi:10.1161/CIRCULATIONAHA.115.017611
Zhang F shun, He Q ze, Qin CH, Little PJ, Weng J ping, Xu S wen. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. Acta Pharmacol Sin. 2022;43(9):2173-2190. doi:10.1038/s41401-021-00835-w
Saji K, Fukumoto Y, Suzuki J, Fukui S, Nawata J, Shimokawa H. Colchicine, a Microtubule Depolymerizing Agent, Inhibits Myocardial Apoptosis in Rats. Tohoku J Exp Med. 2007;213(2):139-148. doi:10.1620/tjem.213.139
Prins KW, Tian L, Wu D, Thenappan T, Metzger JM, Archer SL. Colchicine Depolymerizes Microtubules, Increases Junctophilinâ€2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension. J Am Heart Assoc. 2017;6(6). doi:10.1161/JAHA.117.006195
Bakhta O, Blanchard S, Guihot AL, et al. Cardioprotective Role of Colchicine Against Inflammatory Injury in a Rat Model of Acute Myocardial Infarction. J Cardiovasc Pharmacol Ther. 2018;23(5):446-455. doi:10.1177/1074248418763611
Akodad M, Fauconnier J, Sicard P, et al. Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model. Int J Cardiol. 2017;240:347-353. doi:10.1016/j.ijcard.2017.03.126
Fujisue K, Sugamura K, Kurokawa H, et al. Colchicine Improves Survival, Left Ventricular Remodeling, and Chronic Cardiac Function After Acute Myocardial Infarction. Circulation Journal. 2017;81(8):1174-1182. doi:10.1253/circj.CJ-16-0949
Hennessy T, Soh L, Bowman M, et al. The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction. Am Heart J. 2019;215:62-69. doi:10.1016/j.ahj.2019.06.003
Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. New England Journal of Medicine. 2019;381(26):2497-2505. doi:10.1056/NEJMoa1912388
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).